Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - lactic acid; salicylic acid - cream - 20mg/1gram ; 10mg/1gram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - lactic acid; salicylic acid - paint - 150mg/1gram ; 167mg/1gram

Spojené státy - angličtina - NLM (National Library of Medicine)

sincerus florida, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz), lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at) -

Spojené státy - angličtina - NLM (National Library of Medicine)

meda inc. - hydrogen peroxide (unii: bbx060an9v) (hydrogen peroxide - unii:bbx060an9v), dodecylbenzenesulfonic acid (unii: 60nsk897g9) (dodecylbenzenesulfonic acid - unii:60nsk897g9), lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at) - directions: important: do not further dilute with water or mix with any other teat dips. if product in dip cup becomes visibly dirty, discard contents and replenish with fresh product. do not reuse or return any unused product to the original container. udder prep: when using an udder wash step before milking, make sure to wash teats with appropriate udder wash solution using proper cleaning procedures. teats should then be dried with single-service towels. directions for teat dipping pre-milk dipping: before each cow is milked, and using fresh chem-star sentinel plus, dip each teat full-length into the teat dip cup. wipe teats after dipping using single-service towels to avoid contamination of milk. post-milk dipping: using fresh chem-star sentinel plus, dip each teat full-length into the teat dip cup. do not wipe. allow to air dry. do not turn cows out in freezing weather until the product is completely dry. directions for teat spraying pre-milk spraying: before each cow is milked, and using fresh chem

Spojené státy - angličtina - NLM (National Library of Medicine)

evofem, inc. - lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9ffu82n), citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl), potassium bitartrate (unii: npt6p8p3uu) (tartaric acid - unii:w4888i119h) - phexxi is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. limitations of use phexxi is not effective for the prevention of pregnancy when administered after intercourse [see dosage and administration (2.1)]. risk summary there is no use for phexxi in pregnancy; therefore, discontinue phexxi during pregnancy. there are no data with the use of phexxi in pregnant women or animals. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4 percent and 15 to 20 percent, respectively. risk summary there are no data on the presence of lactic acid, citric acid, and potassium bitartrate or their metabolites in human milk, the effects on the breastfed infant, or the effects on milk production. the safety and effectiveness of phexxi have been established in females of reproductive potential. efficacy is expected to be the same for post-menarchal females

Spojené státy - angličtina - NLM (National Library of Medicine)

fosun pharma usa inc - zoledronic acid (unii: 6xc1pad3kf) (zoledronic acid anhydrous - unii:70hz18ph24) - zoledronic acid injection is indicated for treatment of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, diagnosed by bone mineral density (bmd) or prevalent vertebral fracture, zoledronic acid injection reduces the incidence of fractures (hip, vertebral and non-vertebral osteoporosis-related fractures). in patients at high risk of fracture, defined as a recent low-trauma hip fracture, zoledronic acid injection reduces the incidence of new clinical fractures [ see clinical studies (14.1) ]. zoledronic acid injection is indicated for prevention of osteoporosis in postmenopausal women [ see clinical studies (14.2) ]. zoledronic acid injection is indicated for treatment to increase bone mass in men with osteoporosis [ see clinical studies (14.3) ]. zoledronic acid injection is indicated for the treatment and prevention o

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

nice-pak products (nz) ltd - lactic acid 16.7%{relative}; salicylic acid 16.7%{relative};  ; lactic acid 15%{relative} ((absolute)); salicylic acid 16.7%{relative} - topical solution - active: lactic acid 16.7%{relative} salicylic acid 16.7%{relative}   excipient: pyroxylin active: lactic acid 15%{relative} ((absolute)) salicylic acid 16.7%{relative} excipient: pyroxylin - latest regulatory activity

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

uniphar plc - acetylsalicylic acid - tablets gastro-resistant - 75 milligram - platelet aggregation inhibitors excl. heparin

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

dermal laboratories ltd - lactic acid; salicylic acid - collodion - 16.7%w/w +16.7 percent weight/weight - wart and anti-corn preparations

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

dermal laboratories ltd - salicylic acid; lactic acid - gel - 12.0 %w/w + 4.0 percent weight/weight - wart and anti-corn preparations